TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ)
$6.04 -0.38 (-5.919%)
Analysed TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) News Sources
Tonix Pharmaceuticals Announces Positive Minutes from Type C FDA Meeting to Discuss Adaptive Phase 2 Field Study of TNX-4800, a Human, anti-OspA Monoclonal Antibody, to Prevent Lyme Disease in the U.S.
03-08-2026
yahoo.com
Tonix Pharmaceuticals Q2 Earnings Call Highlights
10-08-2026
marketbeat.com
Tonix Pharmaceuticals Holding Corp (TNXP) (Q2 2026) Earnings Call Highlights: TONMYA Surges ...
10-08-2026
yahoo.com
Tonix Pharmaceuticals (TNXP) Q2 2026 Earnings Call Transcript
17-08-2026
fool.com
Tonix Pharmaceuticals Highlights TONMYA Sales Surge, Lyme and Depression Pipeline
18-08-2026
marketbeat.com
Tonix Pharmaceuticals to Participate in Cantor’s 2026 Global Healthcare Conference
02-09-2026
yahoo.com
TNXP: $11.0 Million in Tonmya® Net Revenue in 2Q26
02-09-2026
yahoo.com
Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer
08-09-2026
yahoo.com
Tonix Pharmaceuticals Targets TONMYA Growth as Lyme Prevention Trial Nears
12-09-2026
marketbeat.com
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Europe 2026
15-10-2026
yahoo.com
What is the current price of TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ)?
The current price of TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) is $6.04.
TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) absolute price change since previous trading day?
The absolute price change of TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) since the previous trading day is $-0.38.
TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) percentage price change since previous trading day?
The percentage price change of TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) since the previous trading day is -5.919%.
What is the most recent average sentiment score for TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ)?
The most recent average sentiment score for TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ)?
The most recent sentiment for TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) is .
SEC-8K** Filing Available For TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.